Last update: March 23, 2018
Minimal risk for breastfeeding and infant.
A second generation antihistamine, derived from piperazine and hydroxyzine metabolite, with minimal sedative effects and very low toxicity even at high doses.
No problems were detected in the short or long term in an infant whose mother took it during the first month after delivery as part of the treatment for pemphigus (Westermann 2012).
Its high binding to plasma proteins makes its transfer to milk very unlikely.
The British Society for Allergy and Clinical Immunology and other experts consider it safe during breastfeeding (Butler 2014, Powell 2007).
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) from Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM